Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2022-01-13 Board/Management Inform…
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that, Mr. Rajaram Narayanan, Managing Director of the Company ....
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the resignation of the Managing Director of Sanofi India Limited. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including changes in management. The content focuses on the resignation and appreciation of the outgoing Managing Director, with no financial data or report attached. The document also includes a press release about the resignation. This fits the category of Board/Management Information (MANG), as it announces a change in senior management. The document length is about 5,138 characters, which is sufficient for a detailed management change announcement but does not contain financial statements or other report data. Therefore, the correct classification is MANG with high confidence.
2022-01-13 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a short letter dated January 6, 2022, addressed to stock exchanges, providing a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations for the quarter ended December 31, 2021. It is signed by the Company Secretary and Compliance Officer. The document is only 1130 characters long and does not contain any financial data or detailed report content. It is a certification letter related to regulatory compliance, not a full financial report or announcement of voting results, management changes, or other categories. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS).
2022-01-06 English
Loss of Share Certificates
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issuance of duplicate share certificates due to lost or misplaced original certificates. It references compliance with SEBI Listing Obligations and Disclosure Requirements, Regulation 39(3). The content is an announcement about share certificate replacement, not a financial report, management change, or voting result. It does not contain financial data or detailed report content. This fits the category of Share Issue/Capital Change announcements, specifically about share certificates.
2022-01-06 English
Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company has provided the enclosed certificate for the quarter ended 31st December 2021 under Regulation ....
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, provided by the Registrar and Share Transfer Agent (RTA) for the quarter ended 31st December 2021. It is a confirmation certificate related to dematerialisation of securities and compliance with SEBI regulations. The document is short (2550 characters) and primarily serves as a certification or confirmation letter rather than a full financial report or detailed filing. It does not contain financial statements or substantive financial data. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is a regulatory compliance document and certification rather than a full report or announcement of a report.
2022-01-06 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issuance of duplicate share certificates due to lost or misplaced originals. It references compliance with SEBI Listing Obligations and Disclosure Requirements, specifically Regulation 39(3). The content is an announcement about share certificate replacement, not a financial report, management change, or voting result. It does not contain financial data, earnings, or governance details. This fits the category of a Regulatory Filing (RNS) as it is a compliance-related announcement that does not fit other specific categories.
2022-01-06 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing them about the closure of the trading window in relation to the upcoming declaration of financial results for the year ending 31st December 2021. It is a notification about insider trading restrictions and does not contain any financial data, results, or detailed report content. The document length is short (1113 characters) and it serves as an announcement rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-12-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.